Having abnormal cells means that a sample of your tissue, examined under a microscope, contains cells that look or behave differently from what a pathologist expects to see in that location. In most cases, the finding comes from a routine screening test and does not mean you have cancer. Abnormal cells exist on a wide spectrum, from harmless changes your body may resolve on its own to more serious shifts that need treatment. Understanding where you fall on that spectrum, and what your doctor plans to do about it, can make the difference between unnecessary panic and appropriate action.
What Makes a Cell “Abnormal”
Your body constantly produces new cells by dividing existing ones. Normally, this process is tightly controlled: cells divide when needed, mature into the right type for their tissue, and stop growing once they’ve done their job. An abnormal cell is one where something in that process has gone wrong. The cell’s size, shape, or internal structure looks different under a microscope, or the cell is dividing faster than it should, or it’s showing up in a tissue where it doesn’t belong.
Several forces can push cells toward abnormality. Chronic inflammation is one of the most studied. When tissues stay inflamed over long periods, the inflammatory environment generates reactive oxygen species, which are chemically aggressive molecules that can damage a cell’s DNA. That DNA damage, if not properly repaired, can alter how the cell grows and divides.1PubMed Central. Molecular mechanisms underlying chronic inflammation-associated cancers Chronic inflammation affects every stage of potential tumor development, from the earliest cellular changes through later progression.2PubMed Central. The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis
Environmental exposures can also be responsible. Research on cadmium, a toxic metal found in cigarette smoke and certain industrial settings, shows that prolonged exposure increases DNA damage while simultaneously reducing the cell’s ability to repair that damage. The combination of more errors and fewer repairs leads to genomic instability, a state where the cell’s genetic instructions become increasingly unreliable, eventually pushing the cell toward malignant transformation.3PubMed Central. Cadmium induced cell apoptosis, DNA damage, decreased DNA repair capacity, and genomic instability during malignant transformation of human bronchial epithelial cells Viruses are another major driver. High-risk strains of human papillomavirus (HPV) are found in nearly all cases of cervical dysplasia and cervical cancer, making the virus the primary cause of abnormal cervical cells.4Wiley Online Library / Cancer. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma
Dysplasia, Hyperplasia, and Metaplasia Are Not the Same Thing
When doctors describe abnormal cells, they use specific terms that mean very different things. If you hear any of these after a screening test, understanding what each one refers to can save you a lot of unnecessary worry.
Hyperplasia simply means there are more cells than usual in a tissue, causing it to enlarge. The cells themselves look normal; there are just too many of them. Metaplasia describes a situation where one type of mature cell in a tissue gets replaced by a different cell type that doesn’t normally live there. Metaplasia is reversible and not inherently dangerous on its own, though it can sometimes precede more concerning changes.5Journal of Interdisciplinary Histopathology. Dysplasia: Understanding the Abnormal Cellular Changes
Dysplasia is where things get more clinically significant. In dysplasia, the cells themselves are atypical: they may be an unusual size or shape, their internal organization is disordered, or they’re dividing more rapidly than normal cells. Dysplasia is the term most people are actually hearing when a doctor says they have “abnormal cells,” especially in the context of cervical, colorectal, or oral screenings. But even dysplasia has a wide range, from mild changes that often disappear without treatment to severe changes that need prompt intervention.
How Abnormal Cells Are Graded
Pathologists don’t simply label cells as “normal” or “abnormal” and leave it at that. They grade the severity because the grade determines what happens next. In cervical screening, for instance, abnormal cells are typically classified as low-grade or high-grade. Low-grade changes, sometimes called CIN 1, mean only slight alterations are present in the cells, and in many cases these changes resolve on their own without treatment. High-grade changes (CIN 2 or CIN 3) indicate more severe abnormalities that are more likely to progress to cancer over time if left untreated.
This grading system is not unique to the cervix. Colorectal polyps, for example, are classified based on features like their size, the types of cells they contain, and how disordered those cells appear. Colorectal cancer develops through a stepwise accumulation of genetic changes, progressing from precancerous growths called adenomas through increasingly advanced stages before becoming a true cancer.6PubMed Central. Pathways of Colorectal Carcinogenesis The concept of a gradual progression from normal tissue to a benign growth to cancer, known as the adenoma-carcinoma sequence, is one of the best-understood models in cancer biology.7PubMed. The adenoma-carcinoma sequence in colorectal neoplasia
The key takeaway from grading is that it reflects probability, not certainty. A high-grade result means the risk of progression is real and warrants action. A low-grade result means the risk is low enough that watchful waiting is often the recommended approach. Your doctor’s recommendation will depend heavily on the grade.
The Line Between Abnormal Cells and Cancer
One of the most important distinctions in pathology is whether abnormal cells have stayed within their tissue of origin or have broken through a barrier called the basement membrane. Think of the basement membrane as a thin boundary layer that separates the surface tissue from the deeper layers of the body. Non-invasive abnormal cells, even when they look quite atypical, remain on one side of this boundary and are classified as benign. Once cells breach the basement membrane, they gain the ability to spread to other parts of the body, and this is the point at which the condition becomes an invasive cancer.8PubMed Central. Force-dependent breaching of the basement membrane
This means that even a diagnosis of “high-grade dysplasia” or “carcinoma in situ” (which literally means cancer in place) is fundamentally different from a diagnosis of invasive cancer. The cells may look alarming under a microscope, but as long as they haven’t crossed that boundary, the prognosis is dramatically better, and treatment is typically straightforward. Screening programs exist precisely to catch cells at this pre-invasive stage, when removing or treating them can prevent cancer from ever developing.
Where Abnormal Cells Show Up Most Often
Abnormal cells can theoretically appear in any tissue, but screening programs are designed around the organs where catching them early makes the biggest difference.
Cervical Screening
The Pap smear (or Pap test) is the most familiar screening tool associated with abnormal cells. It collects cells from the surface of the cervix and examines them for changes. HPV testing is increasingly used alongside or instead of the Pap smear because high-risk HPV strains are present in virtually all cervical dysplasia and cervical cancer. Standard cervical cytology alone can miss up to a quarter of cases, which is why adding HPV testing and molecular markers like p16 helps identify underlying high-grade lesions that the Pap smear alone might not catch.4Wiley Online Library / Cancer. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma When results come back abnormal, a colposcopy, where a doctor examines the cervix more closely and may take a small tissue sample, is often the next step.
Colorectal Screening
During a colonoscopy, doctors look for polyps, small growths on the inner lining of the colon. Most polyps are benign and will never become cancer, but some contain abnormal cells that could progress over years. Removing these polyps during the colonoscopy is one of the most effective cancer prevention strategies available, because it interrupts the progression from benign growth to cancer before it has a chance to complete.
Skin Lesions
Actinic keratoses are rough, scaly patches on sun-exposed skin that represent abnormal cell changes caused by ultraviolet damage. A large study following over 17,000 patients in Sweden found that people diagnosed with actinic keratosis had roughly five times the overall risk of developing skin cancer compared with controls. The risk was highest for squamous cell carcinoma, at about eight times the risk, and somewhat lower for basal cell carcinoma and melanoma.9PubMed Central. Actinic Keratosis Diagnosis and Increased Risk of Developing Skin Cancer: A 10-year Cohort Study of 17,651 Patients in Sweden This makes actinic keratosis a useful warning sign, not just of the lesion itself, but of overall skin cancer risk due to cumulative sun exposure.
How Doctors Investigate Further
Once abnormal cells are found on a screening test, the next step depends on the organ, the severity of the changes, and your overall risk profile. The gold standard remains a biopsy: removing a small piece of tissue so a pathologist can examine it under a microscope in detail. A biopsy gives far more information than a screening test because the pathologist can assess the tissue’s architecture, see how deep the changes go, and look for signs of invasion.
Biomarkers are increasingly used to add precision to the evaluation. In cervical screening, dual-staining tests that look for two proteins, p16 and Ki-67, help distinguish cells that are truly progressing toward cancer from those that just look a little off. Research shows that the proportion of cells positive for these markers climbs steeply with increasing severity: around 47 percent in low-grade lesions, about 83 percent in moderate-grade lesions, and over 90 percent in high-grade lesions.10Clinical Cancer Research. Performance of p16/Ki-67 Immunostaining to Detect Cervical Cancer Precursors in a Colposcopy Referral Population This kind of marker testing helps doctors decide who truly needs treatment and who can be safely monitored, reducing unnecessary procedures.
On the more experimental end, liquid biopsies are emerging as a way to detect abnormal cellular changes through a blood draw rather than tissue sampling. These tests look for fragments of tumor DNA circulating in the bloodstream. While still early in clinical application for most cancers, circulating tumor DNA analysis offers the possibility of non-invasive screening and monitoring, especially for patients at high risk of recurrence after treatment.11PubMed Central. Liquid biopsy: Comprehensive overview of circulating tumor DNA For some cancer types, such as liver cancer, ctDNA detection is being explored as a tool for earlier diagnosis than traditional imaging allows.12PubMed Central. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
Why Abnormal Cell Results Cause So Much Anxiety
If you’ve received a result saying you have abnormal cells and immediately spiraled into worst-case thinking, you’re in very large company. The emotional fallout from these results is well documented and, honestly, underestimated by many healthcare systems.
A study of women who received borderline or mildly abnormal Pap smear results found that about half reported high anxiety afterward. They were nearly three times as likely to describe screening as frightening compared with women who had normal results, and roughly a quarter cited fear of cancer as their primary reason for returning for follow-up testing.13PubMed. Anxiety and borderline PAP smear results Another survey found that anxiety was the most commonly reported emotion at about 37 percent, followed closely by worry and fear. The distress was not evenly distributed across the process, either. Waiting periods, the interval between getting results and having a follow-up procedure, were the most psychologically difficult phases.14PubMed Central. An online survey on emotions, impact on everyday life, and educational needs of women with HPV positivity or abnormal Pap smear result
What makes the anxiety worse is confusion. Research involving women referred for colposcopy after abnormal cervical screening found that most did not understand what their results actually meant, did not know what a colposcopy was before being told they needed one, and turned to the internet for answers, only to find worst-case scenarios and generic information that deepened rather than resolved their confusion.15PubMed Central. Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy – “the land of the unknown” Qualitative interviews with women who received abnormal smear results tell a similar story: many were not informed ahead of time about how abnormal results would be communicated or what the results would mean, leaving them blindsided by fears of cancer, disappointment in their bodies, and worries about reproduction.
If you’re dealing with this right now, the single most useful thing you can do is ask your doctor to explain the specific grade and type of abnormality found, what the next step is, and what the realistic probability of serious progression looks like for your particular result. Generic reassurance (“Don’t worry, it’s probably nothing”) is less helpful than concrete information.
What Happens When Abnormal Cells Are Left Alone
Not all abnormal cells progress, and understanding this is crucial to making sense of your results. Low-grade cervical dysplasia, for example, resolves on its own in the majority of cases. The immune system often clears the HPV infection driving the changes, and the cervical cells return to normal without any treatment. This is why doctors frequently recommend a “watch and wait” approach for low-grade findings: repeat testing in six to twelve months rather than immediate intervention.
High-grade dysplasia is a different situation. While even some high-grade changes can occasionally regress, the risk of progression to invasive cancer is high enough that treatment is generally recommended. The decision is not about whether high-grade dysplasia will definitely become cancer, because it won’t always, but about whether the risk justifies the relatively minor procedure needed to remove it versus the potentially serious consequences of waiting and being wrong.
In the colon, the timeline is longer. Colorectal adenomas typically take years to accumulate the genetic changes needed to progress to cancer. That slow timeline is exactly what makes colonoscopy screening effective: even if a polyp with abnormal cells is found, it has usually been growing slowly for years and is still in a stage where simple removal solves the problem.
What Abnormal Cells Look Like Under the Microscope
You might wonder what exactly a pathologist sees when they call cells abnormal. In normal tissue, cells are uniformly shaped, evenly spaced, and dividing at a predictable rate. In dysplastic tissue, the cells vary in size, their nuclei (the compartment holding DNA) may be larger or irregularly shaped, and the orderly arrangement of the tissue is disrupted. The more disorganized the tissue looks, the higher the grade of dysplasia.
One specific feature pathologists look for is atypical mitosis, which means cells dividing in an abnormal way. In healthy tissue, cell division follows a precise choreography to ensure each daughter cell gets the right number of chromosomes. In abnormal tissue, the division machinery can go haywire: chromosomes get unevenly distributed, the dividing cell forms unusual shapes, or the process stalls partway through. Studies of pancreatic cancer cells found that about 30 percent of cell divisions were atypical, while normal tissue showed none, and precancerous lesions showed only a few instances.16IntechOpen. Chromosomal Abnormalities – A Hallmark Manifestation of Genomic Instability These atypical divisions are linked to genomic instability, a hallmark of cells heading in a dangerous direction.
Reducing Your Risk of Developing Abnormal Cells
Prevention strategies depend on which tissue you’re concerned about. For cervical abnormalities, HPV vaccination is the most powerful tool available, preventing infection with the high-risk HPV strains responsible for the vast majority of cervical dysplasia and cancer. Routine screening catches changes that vaccination misses or that developed before vaccination was available.
For skin, the evidence linking actinic keratosis to future skin cancer risk reinforces what dermatologists have said for decades: consistent sun protection, including sunscreen, protective clothing, and avoiding peak UV hours, reduces the accumulation of the ultraviolet damage that drives abnormal skin cell changes.9PubMed Central. Actinic Keratosis Diagnosis and Increased Risk of Developing Skin Cancer: A 10-year Cohort Study of 17,651 Patients in Sweden
For colorectal abnormalities, screening itself is prevention. Colonoscopy allows doctors to remove polyps before they ever progress. There is also ongoing research into chemoprevention, the use of medications to reduce the risk of precancerous lesions forming in the first place, particularly for people at high genetic risk of colorectal cancer.17PubMed Central. Chemoprophylaxis of precancerous lesions in patients who are at a high risk of developing colorectal cancer For stomach cancer, researchers are evaluating agents like anti-inflammatory drugs, antioxidants, and even metformin as potential ways to slow or reverse precancerous gastric changes, though none has yet been proven effective enough for routine clinical use.18QJM: An International Journal of Medicine. Chemoprevention strategies for precancerous gastric lesions beyond Helicobacter pylori eradication
Aging and Abnormal Cells
As you get older, the likelihood of finding abnormal cells goes up. This happens for two interconnected reasons. First, the longer you live, the more time your cells have to accumulate DNA damage from environmental exposures, chronic inflammation, and the simple imperfection of the cell-copying process. Second, aging itself changes how cells behave. Older organisms accumulate senescent cells, cells that have stopped dividing but remain metabolically active and can influence their neighbors through the inflammatory signals they release. The buildup of senescent cells is closely linked to age-related diseases, and the altered metabolic environment they create can contribute to conditions favorable for abnormal cell development.
This is part of why screening recommendations are tied to age ranges. Colonoscopy screening, for instance, is recommended starting in your mid-40s precisely because the accumulated risk of abnormal colorectal changes becomes meaningful at that point. The same logic applies to other screening programs: they target the age windows where the yield of finding treatable abnormalities is highest.